Management of Medication-related Osteonecrosis of the Jaw An Issue of Oral and Maxillofacial Clinics of North America 1st Edition at Meripustak

Management of Medication-related Osteonecrosis of the Jaw An Issue of Oral and Maxillofacial Clinics of North America 1st Edition

Books from same Author: Ruggiero, Salvatore

Books from same Publisher: Elseiver

Related Category: Author List / Publisher List


  • Retail Price: ₹ 8771/- [ 5.00% off ]

    Seller Price: ₹ 8332

Sold By: Book Upload      Click for Bulk Order

Offer 1: Get ₹ 111 extra discount on minimum ₹ 500 [Use Code: Bharat]

Offer 2: Get 5.00 % + Flat ₹ 100 discount on shopping of ₹ 1500 [Use Code: IND100]

Offer 3: Get 5.00 % + Flat ₹ 300 discount on shopping of ₹ 5000 [Use Code: MPSTK300]

Free Shipping (for orders above ₹ 499) *T&C apply.

In Stock

Free Shipping Available



Click for International Orders
  • Provide Fastest Delivery

  • 100% Original Guaranteed
  • General Information  
    Author(s)Ruggiero, Salvatore
    PublisherElseiver
    Edition1st Edition
    ISBN9780323413466
    LanguageEnglish
    Publish YearNovember 2015

    Description

    Elseiver Management of Medication-related Osteonecrosis of the Jaw An Issue of Oral and Maxillofacial Clinics of North America 1st Edition by Ruggiero, Salvatore

    Editor Salvatore Ruggiero, DMD, MD and authors review the Diagnosis, Management and Prevention of Medication-related Osteonecrosis of the Jaw. Articles will include: Osteoporosis and bone modulation therapies: indications and outcomes; Antiresorptive therapies for the treatment of malignant osteolytic bone disease; Clinical presentation and staging of antiresorptive agent-induced osteonecrosis of the jaw; Epidemiology and risk factors of antiresorptive agent-induced osteonecrosis of the jaw; Basic science research of antiresorptive agent-induced osteonecrosis of the jaw: an update; Pathophysiology of antiresorptive agent-induced osteonecrosis of the jaw: what we know and what we don't know; The genetics of osteonecrosis of the jaw; Preventive strategies for patients at risk of antiresorptive agent-induced osteonecrosis of the jaw; Non-operative and operative therapies for treatment of antiresorptive agent-induced osteonecrosis of the jaw; The role of anti-angiogenic therapy in the development of osteonecrosis of the jaw; Antiresorptive therapies: what they are and how do they work, and more!_x000D_